» Articles » PMID: 35779801

Temporal Trends in Clinical Characteristics and In-hospital Mortality Among Patients with COVID-19 in Japan for Waves 1, 2, and 3: A Retrospective Cohort Study

Overview
Publisher Elsevier
Date 2022 Jul 2
PMID 35779801
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3.

Methods: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included.

Results: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17-4.07%; relative risk reduction = 23-59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98-11.68%; relative risk reduction = 22-60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66-4.05%; relative risk reduction = 24-50%).

Conclusions: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients.

Citing Articles

COVID-19 inpatient care performance in the unified health system, São Paulo state, Brazil: an application of standardized mortality ratio for hospitals' comparisons : COVID-19 inpatient care performance in SUS, Brazil.

Schilling M, Portela M, de Albuquerque M, Martins M BMC Health Serv Res. 2024; 24(1):1125.

PMID: 39334045 PMC: 11428977. DOI: 10.1186/s12913-024-11496-w.


Acute and chronic kidney disease and risk of hospital mortality during COVID-19 pandemic waves in the pre-vaccination era.

Portoles J, Lopez-Sanchez P, Martin-Rodriguez L, Serrano-Salazar M, Valdenebro-Recio M, Ramos A Clin Kidney J. 2023; 16(2):374-383.

PMID: 36751624 PMC: 9620382. DOI: 10.1093/ckj/sfac239.


Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: A cross-sectional analysis of 72,459 inpatient cases from the German Helios database.

Konig S, Hohenstein S, Pellissier V, Leiner J, Hindricks G, Nachtigall I Front Public Health. 2022; 10:1028062.

PMID: 36420010 PMC: 9678052. DOI: 10.3389/fpubh.2022.1028062.

References
1.
Roth G, Emmons-Bell S, Alger H, Bradley S, Das S, de Lemos J . Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic. JAMA Netw Open. 2021; 4(5):e218828. PMC: 8094014. DOI: 10.1001/jamanetworkopen.2021.8828. View

2.
Zacharioudakis I, Prasad P, Zervou F, Basu A, Inglima K, Weisenberg S . Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19. Ann Am Thorac Soc. 2020; 18(5):900-903. PMC: 8086542. DOI: 10.1513/AnnalsATS.202008-931RL. View

3.
Marshall A, Altman D, Holder R, Royston P . Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009; 9:57. PMC: 2727536. DOI: 10.1186/1471-2288-9-57. View

4.
Gandhi M, Rutherford G . Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine. N Engl J Med. 2020; 383(18):e101. PMC: 7890559. DOI: 10.1056/NEJMp2026913. View

5.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View